SCHEMBL9526405

SCHEMBL9526405

CCOC(=O)C(CCc1ccccc1)NC1CSC(c2ccccc2)CN(CC(=O)OC(C)(C)C)C1=O

nearest known ligand 0.66

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.47
ABCB11 O95342 1/20 0.47
AGTR2 P50052 1/20 0.47
PDE3A Q14432 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9524662 0.94 ACE (0.42) ACE
SCHEMBL9526358 0.94 ACE (0.42) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10376309 0.92 ABCB11 (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10376687 0.92 ABCB11 (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10378434 0.92 ABCB11 (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10378433 0.92 ABCB11 (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526655 0.92 ACE (0.43) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10378593 0.90 ACE (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10377822 0.90 ACE (0.46) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL10376311 0.90 ACE (0.46) ACEABCB11AGTR2PDE3ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed
US-4699905-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1987-10-13 US disclosed
EP-0161801-A2 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1985-11-21 EP disclosed